These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27890725)

  • 1. Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.
    Mallipeddi S; Janero DR; Zvonok N; Makriyannis A
    Biochem Pharmacol; 2017 Mar; 128():1-11. PubMed ID: 27890725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonists.
    Patel M; Finlay DB; Glass M
    Cell Signal; 2021 Feb; 78():109865. PubMed ID: 33259937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
    Manning JJ; Green HM; Glass M; Finlay DB
    Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB
    Ryalls B; Patel M; Sparkes E; Banister SD; Finlay DB; Glass M
    Biochem Pharmacol; 2024 Apr; 222():116052. PubMed ID: 38354957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
    Wouters E; Walraed J; Banister SD; Stove CP
    Biochem Pharmacol; 2019 Nov; 169():113623. PubMed ID: 31472128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
    Grey J; Terry P; Higgs S
    Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.
    Nimczick M; Decker M
    ChemMedChem; 2015 May; 10(5):773-86. PubMed ID: 25820617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
    Janero DR; Korde A; Makriyannis A
    Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
    Prather PL; FrancisDevaraj F; Dates CR; Greer AK; Bratton SM; Ford BM; Franks LN; Radominska-Pandya A
    Biochem Biophys Res Commun; 2013 Nov; 441(2):339-43. PubMed ID: 24148245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
    Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington's Disease.
    Bagher AM; Laprairie RB; Kelly MEM; Denovan-Wright EM
    Methods Mol Biol; 2018; 1780():549-571. PubMed ID: 29856035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the evolutionary trajectory and functional landscape of cannabinoid receptors: A comprehensive bioinformatic analysis.
    Soobben M; Sayed Y; Achilonu I
    Comput Biol Chem; 2024 Oct; 112():108138. PubMed ID: 38943725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational potential of allosteric modulators targeting the cannabinoid CB
    Lu D; Immadi SS; Wu Z; Kendall DA
    Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.
    Krishna Kumar K; Shalev-Benami M; Robertson MJ; Hu H; Banister SD; Hollingsworth SA; Latorraca NR; Kato HE; Hilger D; Maeda S; Weis WI; Farrens DL; Dror RO; Malhotra SV; Kobilka BK; Skiniotis G
    Cell; 2019 Jan; 176(3):448-458.e12. PubMed ID: 30639101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.
    Páez JA; Campillo NE
    Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Selectivity at Cannabinoid Receptors.
    Priestley R; Glass M; Kendall D
    Adv Pharmacol; 2017; 80():207-221. PubMed ID: 28826535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
    Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
    Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for ligand modulation of the cannabinoid CB
    Ramesh K; Rosenbaum DM
    Br J Pharmacol; 2022 Jul; 179(14):3487-3495. PubMed ID: 34265078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.